Chargement en cours...
A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy.
Temozolomide is a novel second-generation oral alkylating agent with demonstrated efficacy and safety in patients with recurrent glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA). A multicenter phase II trial was conducted to determine the efficacy and safety of temozolomide before radio...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2002
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1920664/ https://ncbi.nlm.nih.gov/pubmed/12356356 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|